Hiba Hamdar | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Hiba Hamdar, MD Emergency Medicine Physician, Medical Researcher and HealthTech Innovator, Medical Learning Skills Academy, Germany

Hiba Hamdar
Affiliation Medical Learning Skills Academy
Country Germany
Google Scholar ga_S3XAAAAAJ
Documents 58
Citations 100
h-index 5
Subject Area Artificial Intelligence
Event Top Teachers Awards
Scopus ID 57196075496
ORCID 0000-0002-4488-7323

Hiba Hamdar, MD, is an emergency medicine physician and medical researcher whose professional activities combine clinical medicine, medical education, evidence-based research and health technology. Her academic profile records 58 documents, 100 citations and an h-index of 5. Her work also includes development of technology-supported medical learning environments and research-oriented educational initiatives. [1]

Abstract

Hiba Hamdar is an MD-qualified emergency medicine physician, researcher and health technology innovator with professional experience spanning emergency care, clinical training, medical education and digital health. Her academic activities encompass medical research, systematic review methods, clinical case work and interdisciplinary collaboration. She founded the Medical Learning Skills Academy and developed the MLS Virtual Hospital, an AI-supported clinical training environment designed to provide learners with structured practice in history-taking, diagnosis, investigation interpretation and procedural learning. The project has been deposited in Zenodo and assigned DOI 10.5281/zenodo.20392558. [3]

Keywords

Artificial intelligence; medical education; emergency medicine; digital health; health technology; clinical simulation; machine learning; medical research; evidence-based medicine; Python; Streamlit; clinical decision support.

Introduction

Hiba Hamdar’s professional profile is situated at the intersection of clinical practice, medical education and emerging health technologies. Following her Doctor of Medicine education at the Medical University of Plovdiv, she developed clinical experience in emergency medicine together with rotations and internships in obstetrics and gynecology, hematology, oncology, cardiology, cardiovascular surgery, pediatric surgery and internal medicine. Her stated research interests include academic medicine, abdominal tuberculosis, neurochemical research and other clinical and biomedical subjects.

Her professional activities subsequently expanded toward digital medical education. Through the Medical Learning Skills Academy, she has developed educational programs intended to connect theoretical medical knowledge with practical clinical competencies. This approach includes structured learning in anamnesis, physical examination, electrocardiographic and imaging interpretation, resuscitation, procedural skills and clinical case presentation.

Research Profile

Hiba Hamdar’s research profile combines clinical medicine with health technology and educational innovation. Her documented academic record includes 58 documents, 100 citations and an h-index of 5 and Scopus profile records 22 documents, 74 citations, and an h-index of 5.[1][2] Her research and professional interests cover general and internal medicine, cardiovascular medicine, health care sciences, neurosciences and experimental medicine, while artificial intelligence and digital health represent important components of her technology-oriented work.

Her technical activities include Python programming, Streamlit application development, electronic health record concepts, retrieval-augmented generation systems, artificial-intelligence and large-language-model integration, medical database management, multiple-choice assessment systems and three-dimensional medical visualization. These skills are applied primarily to medical learning and clinical simulation rather than as independent software-development activities.

Her professional service has included editorial, peer-review and guest-editing responsibilities, together with participation in international research collaborations. She has also been involved in a global surgical outcomes collaboration associated with the HIPPO Global Cohort Study and has led the MLS Rare Cases Global Project.

Research Contributions

A central contribution of Hiba Hamdar’s work is the development of medical-learning infrastructure that combines clinical reasoning with interactive technology. The MLS Virtual Hospital uses Python and Streamlit to provide simulated clinical encounters involving patient history-taking, diagnostic reasoning, laboratory and imaging interpretation and procedural learning. Its reported components include a multiple-choice question system, mentor directory, clinical case library, three-dimensional procedure viewer and retrieval-augmented medical knowledge functionality. [3]

Her research contribution also includes participation in clinical and biomedical literature addressing therapeutic applications and systematic evidence synthesis. Examples supplied in her academic record include research concerning medical gases in cancer treatment and systematic evidence regarding the anti-inflammatory effects of mesenchymal stem cells in burns. [4] [5]

Through the MLS Academy, Hamdar further contributes to medical education by integrating practical clinical skills, research literacy and technology competencies into structured learning activities. Her stated objective is to create a continuous pathway from foundational medical training to clinical reasoning, research production and responsible use of artificial intelligence.

Publications

Hiba Hamdar’s publication and editorial activities span clinical medicine, biomedical research, medical education and emerging health technologies. Her profile reports more than 20 peer-reviewed publications and book chapters, together with editorial involvement in books addressing neuroscience, brain-heart connections, artificial intelligence in smart healthcare systems and infectious diseases. Her publication record is indexed through academic research platforms including Google Scholar and Scopus. [1] [2]

Representative research cited in the supplied academic record includes the 2025 article by Al Bazzal and colleagues on potential therapeutic applications of medical gases in cancer treatment and the 2022 systematic review by Eldaly and colleagues examining systemic anti-inflammatory effects of mesenchymal stem cells in burns. These publications illustrate the broader biomedical research context associated with her academic profile. [4] [5]

Research Impact

The available bibliometric information records 100 citations and an h-index of 5 across 58 documents in the supplied profile data. [1] These indicators provide a quantitative description of the visibility of her indexed research but should be interpreted alongside publication quality, research collaboration, methodological contribution and practical relevance.

A distinctive aspect of her current work is the translation of research and clinical knowledge into digital learning environments. The MLS Virtual Hospital represents an applied technology project in which artificial intelligence, software development and clinical education are brought together in a simulation-based setting. Its Zenodo record provides a persistent scholarly reference for the project. [3]

Her participation in international clinical research and editorial activities additionally indicates engagement beyond individual clinical practice. The combination of clinical experience, research participation, medical education and technology development provides a multidisciplinary basis for continued work in AI-enabled healthcare learning.

Award Suitability

For the Innovative Research Award associated with the Top Teachers Awards, Hiba Hamdar’s profile demonstrates several relevant characteristics: an established clinical and research background, documented scholarly output, participation in peer review and editorial activities, and practical development of technology for medical education. Her work on the MLS Virtual Hospital is particularly relevant to an innovation-focused recognition because it connects clinical training with artificial intelligence, interactive simulation and structured digital learning. [3]

The award suitability assessment is supported by the combination of measurable academic indicators and applied educational innovation. Her profile records 58 documents, 100 citations and an h-index of 5, while her professional activities include founding and directing a medical education academy and contributing to digital-health development. [1] These elements provide a substantive basis for consideration within a research and teaching innovation category.

Conclusion

Hiba Hamdar’s academic and professional profile reflects an interdisciplinary trajectory connecting emergency medicine, biomedical research, medical education and artificial intelligence. Her documented research activity, international collaboration, editorial service and development of the MLS Virtual Hospital demonstrate an emphasis on applying technology to structured medical learning. The combination of scholarly activity and practical health-technology development provides a relevant foundation for recognition in an innovative research and education context.[1]

References

  1. Google Scholar. (n.d.). Hiba Hamdar, Google Scholar author profile. https://scholar.google.com/citations?hl=en&user=ga_S3XAAAAAJ
  2. Elsevier. (n.d.). Scopus author details: Hiba Hamdar, Author ID 57196075496. Scopus. https://www.scopus.com/pages/authors/57196075496
  3. Hamdar, H. (2025). MLS Virtual Hospital. Zenodo. DOI: https://doi.org/10.5281/zenodo.20392558
  4. Hamdar, H, Al Bazzal, A., Hoteit, B. H., Chokor, M., Safawi, A., Zibara, Z., Rizk, F., Kawssan, A., et al. (2025). Potential therapeutic applications of medical gases in cancer treatment. Medical Gas Research, 15(2), 309. https://pmc.ncbi.nlm.nih.gov/articles/PMC11918469/
  5. Hamdar, H, Eldaly, A. S., Mashaly, S. M., Fouda, E., Emam, O. S., Aglan, A., Abuasbeh, J., et al. (2022). Systemic anti-inflammatory effects of mesenchymal stem cells in burn: A systematic review of animal studies. Journal of Clinical and Translational Research, 8(4), 276. https://pmc.ncbi.nlm.nih.gov/articles/PMC9389574/

Song Guo Zheng | Medicine and Health Sciences | Best Innovator Award

Best Innovator Award

Song Guo Zheng
Shanghai Jiao Tong University, China
Song Guo Zheng
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 7403146499
Documents 262
Citations 16,675
h-index 75
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-5611-4774
Google Scholar 37kvQ18AAAAJ

Song Guo Zheng is a physician-scientist and immunologist whose academic career has spanned molecular immunology, rheumatology, autoimmunity, cell therapy, and translational medicine. His research has contributed to the understanding of regulatory T cells, immune tolerance, autoimmune disease mechanisms, and therapeutic immunomodulation. He currently serves as Chair Professor of Medicine and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University School of Medicine while maintaining extensive leadership roles in international scientific organizations and scholarly publishing.[1]

Abstract

This article evaluates the academic achievements, scientific leadership, educational service, and innovation record of Song Guo Zheng in relation to the Best Innovator Award. His work integrates fundamental immunology with translational medicine, resulting in influential publications, patents, edited books, international collaborations, and leadership positions across major scientific societies. The breadth of his contributions demonstrates sustained impact on biomedical research and clinical immunology.[1]

Keywords

Rheumatology, Immunology, Autoimmunity, T Regulatory Cells, Cell Therapy, GMSC, Tumor Immunity.

Introduction

Over several decades, Song Guo Zheng has established an interdisciplinary research program focused on immune regulation, autoimmune disease pathogenesis, regenerative medicine, and therapeutic cell engineering. His academic development includes medical training in China, doctoral education in France, and faculty appointments at major institutions in the United States and China. His scientific output has contributed to both theoretical and applied aspects of immunological science.[1]

Research Profile

Song Guo Zheng earned an M.D. from Anhui Medical University and later completed a Ph.D. in Molecular Immunology at the University of Orleans, France. His academic appointments have included leadership roles at the University of Southern California, Penn State University, Ohio State University, and Shanghai Jiao Tong University. He has also served as editor, associate editor, and editorial board member for numerous high-impact journals while participating in major international grant-review panels and scientific committees.[1]

Research Contributions

  • Advanced understanding of regulatory T-cell biology and immune tolerance mechanisms.[2]
  • Developed strategies for immune modulation relevant to autoimmune disorders and inflammatory diseases.[3]
  • Contributed to translational research in cell therapy, tumor immunity, and regenerative medicine.
  • Secured multiple granted patents involving regulatory T cells, exosome applications, and immunotherapeutic technologies.[1]
  • Edited scientific books and chapters that support education and dissemination of immunological knowledge.

Publications

Representative publications include influential studies on regulatory T-cell induction, immune tolerance, vitamin-mediated immune regulation, and chronic disease immunobiology. These works have become widely cited within immunology and rheumatology literature.[2][3][4][5][6]

Research Impact

According to the provided scholarly metrics, the researcher has produced 262 indexed documents, accumulated more than 16,675+ citations, and achieved an h-index of 75. These indicators reflect substantial scholarly visibility and influence within biomedical sciences. His leadership in international societies, conference organization, editorial service, and research mentoring further extends the impact of his work beyond publication metrics alone.[1]

Award Suitability

The Best Innovator Award recognizes individuals who demonstrate sustained innovation, measurable research impact, educational leadership, and translational achievement. Song Guo Zheng’s portfolio includes pioneering immunological discoveries, numerous patents, extensive publication activity, scientific leadership, international recognition, and contributions to medical education. These accomplishments collectively support strong consideration for recognition within innovation-focused academic award programs.[1]

Conclusion

Song Guo Zheng has developed a distinguished career characterized by innovation in immunology, leadership in academic medicine, and contributions to translational biomedical research. His scientific achievements, educational service, publication record, patents, and international professional engagement provide a substantial foundation for recognition under the Best Innovator Award framework.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Song Guo Zheng, Author ID 7403146499. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7403146499
  2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.172.9.5213
  3. Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7090258
  4. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.4.2018
  5. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.169.8.4183
  6. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging and Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5440113/